These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. Meyer-Schwickerath R; Pfeiffer A; Blum WF; Freyberger H; Klein M; Lösche C; Röllmann R; Schatz H J Clin Invest; 1993 Dec; 92(6):2620-5. PubMed ID: 7504689 [TBL] [Abstract][Full Text] [Related]
26. Impact of diabetic retinopathy on quantitative retinal nerve fiber layer measurement and glaucoma screening. Takahashi H; Chihara E Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):687-92. PubMed ID: 18235015 [TBL] [Abstract][Full Text] [Related]
27. [Adequacy of prescribing the disaggregants in vascular pathology of the eye fundus and in primary open-angle glaucoma]. Mukha AI Vestn Oftalmol; 2005; 121(1):30-3. PubMed ID: 15759845 [TBL] [Abstract][Full Text] [Related]
28. Alcohol and eye diseases. Wang S; Wang JJ; Wong TY Surv Ophthalmol; 2008; 53(5):512-25. PubMed ID: 18929762 [TBL] [Abstract][Full Text] [Related]
29. Hypercapnia- and trans-arachidonic acid-induced retinal microvascular degeneration: implications in the genesis of retinopathy of prematurity. Leduc M; Kermorvant-Duchemin E; Checchin D; Sennlaub F; Sirinyan M; Kooli A; Lachapelle P; Chemtob S Semin Perinatol; 2006 Jun; 30(3):129-38. PubMed ID: 16813971 [TBL] [Abstract][Full Text] [Related]
30. Drug intervention can correct subnormal retinal oxygenation response in experimental diabetic retinopathy. Berkowitz BA; Roberts R; Luan H; Peysakhov J; Knoerzer DL; Connor JR; Hohman TC Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2954-60. PubMed ID: 16043871 [TBL] [Abstract][Full Text] [Related]
35. Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy. Toda N; Nakanishi-Toda M Prog Retin Eye Res; 2007 May; 26(3):205-38. PubMed ID: 17337232 [TBL] [Abstract][Full Text] [Related]
36. Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas. Gastinger MJ; Singh RS; Barber AJ Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3143-50. PubMed ID: 16799061 [TBL] [Abstract][Full Text] [Related]
37. Trends in cost of major eye diseases to Medicare, 1991 to 2000. Salm M; Belsky D; Sloan FA Am J Ophthalmol; 2006 Dec; 142(6):976-82. PubMed ID: 17157582 [TBL] [Abstract][Full Text] [Related]
38. Studies with an orally bioavailable alpha V integrin antagonist in animal models of ocular vasculopathy: retinal neovascularization in mice and retinal vascular permeability in diabetic rats. Santulli RJ; Kinney WA; Ghosh S; Decorte BL; Liu L; Tuman RW; Zhou Z; Huebert N; Bursell SE; Clermont AC; Grant MB; Shaw LC; Mousa SA; Galemmo RA; Johnson DL; Maryanoff BE; Damiano BP J Pharmacol Exp Ther; 2008 Mar; 324(3):894-901. PubMed ID: 18083913 [TBL] [Abstract][Full Text] [Related]
39. Vision-related quality of life in patients with diabetic macular oedema. Hariprasad SM; Mieler WF; Grassi M; Green JL; Jager RD; Miller L Br J Ophthalmol; 2008 Jan; 92(1):89-92. PubMed ID: 17584999 [TBL] [Abstract][Full Text] [Related]
40. Effects of retinal laser photocoagulation on photoreceptor basic fibroblast growth factor and survival. Xiao M; Sastry SM; Li ZY; Possin DE; Chang JH; Klock IB; Milam AH Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):618-30. PubMed ID: 9501874 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]